Imosec

Loperamide Hydrochloride, the active ingredient in Imosec, is an opioid antidiarrheal presented as an oral dosage form for oral use. It works by slowing intestinal transit and is indicated for the management of acute diarrhea, chronic diarrhea, and irritable bowel syndrome with diarrhea in adult patients.

GNH USA supplies Imosec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU pharmacopeial standards and is distributed through regulated channels to ensure quality and safety, with a supply chain that supports rapid fulfillment for institutional and retail customers.

Imosec (loperamide hydrochloride) acts on the gastrointestinal motility pathway to control excessive stool output.

- Acute diarrhea: reduces stool frequency and improves consistency within hours. - Chronic diarrhea: provides sustained symptom control for long‑term management. - Irritable bowel syndrome with diarrhea (IBS‑D): alleviates bowel urgency and loose stools.

Loperamide may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Constipation - Abdominal cramps - Nausea - Dizziness - Dry mouth - Drowsiness

Serious or Rare Side Effects: - Severe constipation or intestinal obstruction - Toxic megacolon - Allergic reactions such as rash, angioedema, or anaphylaxis - Cardiac arrhythmias (QT prolongation) - Urinary retention

When using Imosec, several safety considerations should be observed to minimize risk.

- Infectious diarrhea: avoid use if diarrhea is caused by invasive bacteria or Clostridioides difficile, as slowing motility may worsen infection. - Hepatic impairment: use with caution and consider dose reduction in patients with severe liver disease. - Children under 2 years: not recommended for use in this age group. - Concomitant use with other antidiarrheal agents: avoid combining with additional agents that reduce gut motility. - Pregnancy Category B: generally considered safe, but discuss with a healthcare professional before use. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Loperamide can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma concentrations and risk of cardiac toxicity. - Other opioids or opioid agonists: additive central nervous system depression is unlikely but may increase constipation. - QT‑prolonging drugs (e.g., quinidine, amiodarone): combined use can heighten the risk of arrhythmias.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, antihistamines): may enhance drowsiness or sedation. - Anticholinergic agents: can potentiate constipation. - Antifungal azoles (e.g., itraconazole) at moderate potency: may modestly raise loperamide levels.